SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,339,000 | -23.9% | 121,504 | -8.4% | 0.25% | -17.2% |
| Q2 2019 | $4,388,000 | -15.9% | 132,607 | -11.0% | 0.30% | -8.7% |
| Q1 2019 | $5,220,000 | +7.1% | 148,974 | +1.5% | 0.33% | -5.4% |
| Q4 2018 | $4,875,000 | -40.9% | 146,739 | -10.5% | 0.35% | -23.0% |
| Q3 2018 | $8,255,000 | -23.9% | 163,956 | -9.6% | 0.46% | -25.9% |
| Q2 2018 | $10,850,000 | +18.4% | 181,283 | -9.4% | 0.62% | +21.1% |
| Q1 2018 | $9,162,000 | -11.8% | 200,042 | -23.3% | 0.51% | +2.4% |
| Q4 2017 | $10,388,000 | +48.8% | 260,676 | +49.3% | 0.50% | +74.6% |
| Q3 2017 | $6,983,000 | – | 174,572 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |